Insurance Company M&A: Form A Filings,
State Approvals, and Closing an Insurance Holding Company Deal

Insurance company acquisitions run on two simultaneous clocks. The M&A clock governs purchase agreement negotiation, due diligence, financing, and closing mechanics. The regulatory clock governs Form A preparation, filing completeness review, deficiency response, public notice, and the state commissioner's approval order. Unlike HSR Act premerger notification, which involves a defined waiting period after which the parties are free to close absent an agency action, state insurance regulatory approval is an affirmative prior approval requirement. The parties cannot close without an order, and that order may be conditioned on commitments the acquirer has not yet made. If those two clocks are not synchronized from the outset, the transaction is structurally at risk.

The practical implication is that Form A preparation begins at the letter of intent stage, not after the purchase agreement is executed. Biographical affidavit collection, ownership mapping, financial projection modeling, and pre-filing conferences with domestic state regulators are workstreams that take weeks under the best circumstances. A complex filing for an acquisition by a private equity fund with multi-tier ownership, multiple portfolio company investors, and a foreign limited partner base may take months to prepare. Filing an incomplete Form A resets the statutory clock when the regulator issues a deficiency notice and suspends the review period until all requested materials are received.

The regulatory track also shapes the M&A track. Closing conditions, termination rights, and reverse termination fees in the purchase agreement must account for the regulatory timeline. A drop-dead date that does not allow sufficient time for regulatory approval to issue creates closing risk that may be used by either party as leverage in pre-closing disputes. Counsel experienced in insurance M&A will structure the regulatory approval condition with specific notice obligations, a defined process for responding to deficiencies, and a drop-dead date that reflects the realistic approval timeline for the specific states involved. Getting that structure right at the purchase agreement stage prevents significant friction later in the transaction.

Every state has enacted an insurance holding company act governing the relationships among insurers and their affiliates within a holding company system. Most state acts are based on the National Association of Insurance Commissioners (NAIC) Insurance Holding Company System Regulatory Act Model, which has been amended periodically to address group-level supervision, enterprise risk, and systemic risk concerns. The model law establishes the core framework for Form A change-of-control filings, affiliated transaction oversight, holding company registration requirements, and enterprise risk reporting. Individual states have adopted the model with variations, and counsel must confirm the specific statutory and regulatory requirements of each domestic state involved in a transaction rather than assuming uniformity with the NAIC model.

The holding company act's scope extends beyond the licensed insurer itself to the entire insurance holding company system. Any transaction that results in a change in control at any level of the holding company chain above a domestic insurer requires Form A review, even if the insurer itself is not a direct party to the acquisition agreement. An acquisition of a holding company that sits three tiers above the licensed insurer is still subject to Form A requirements in the insurer's domestic state, because the ultimate controlling person of the insurer has changed. Mapping the holding company chain from the acquired entity down to each licensed insurer is accordingly a threshold step in transaction planning.

States vary in their approaches to affiliated transaction oversight under the holding company act. Most states require prior approval or at least prior notice for transactions between the insurer and its affiliates above specified dollar thresholds, including reinsurance agreements, cost-sharing arrangements, tax-sharing agreements, and management services contracts. In an acquisition context, the buyer's plan for post-closing intercompany arrangements must be evaluated against the affiliated transaction provisions of each domestic state's holding company act. A plan to upstream cash from the insurer to service acquisition debt through a management fee or tax-sharing agreement may require regulatory approval that has not been factored into the deal timeline.

The cornerstone of the insurance holding company act's change-of-control framework is the rebuttable presumption that any person acquiring 10% or more of the voting securities of a domestic insurer or of any other person controlling a domestic insurer has acquired control for purposes of the Form A filing requirement. This threshold is significantly lower than the ownership levels that trigger change-of-control analysis under most other regulatory frameworks, and its application to holding company entities above the insurer extends its reach throughout complex holding company structures. A private equity fund that acquires 10% of the voting interests in a holding company that controls an insurance subsidiary triggers the presumption at the insurer level, even if the fund holds no direct interest in the insurer.

The presumption is rebuttable in most states, but rebuttal is not a simple administrative notice. An acquirer seeking to rebut the presumption must file an application with the domestic state regulator demonstrating that despite crossing the 10% threshold, it does not in fact exercise control over the management, policies, or operations of the insurer. The regulator evaluates the application based on the acquirer's governance rights, representation on the insurer's or holding company's board, contractual rights to approve or veto insurer decisions, and the overall relationship between the acquirer and the insurer's management. Rebuttal is appropriate in limited circumstances, such as passive institutional investors holding diversified positions, but it is not a reliable planning tool for acquirers who intend to have any meaningful involvement in the insurer's affairs.

The 10% threshold analysis must be applied to each class of voting security separately, and to instruments that may convert to voting securities or carry contingent voting rights. Preferred equity with voting rights upon a defined trigger, convertible notes with a conversion feature that would produce more than 10% of a class, and options or warrants exercisable for voting securities must all be analyzed. The analysis is a snapshot at the time of acquisition and may need to be revisited if subsequent financing rounds or equity issuances alter the voting security count. Counsel should identify all instruments carrying actual or potential voting rights and perform the 10% analysis on a fully diluted basis before any acquisition commitment is made.

Form A is the primary regulatory vehicle for obtaining prior approval of a change in control of a domestic insurer. The NAIC model Form A requires disclosure across several categories: the identity and background of each acquiring person, the source and amount of funds used in the acquisition, any plans for a material change in the insurer's business or corporate structure, the number and class of securities to be acquired, any contracts or arrangements relating to the acquisition, and biographical information for each person who will serve as a director or officer of the acquiring entity or the insurer following the transaction. Most domestic state regulators use the NAIC model form with state-specific supplements.

The financial disclosure requirements in Form A are substantial. The filer must provide audited financial statements for each acquiring person, pro forma financial statements showing the combined entity's projected capitalization and solvency position following the acquisition, and a detailed analysis of the acquirer's plans for maintaining the insurer's financial condition. For private equity acquirers, this requires disclosure of fund financials, fund-level debt, portfolio company obligations, and the capital plan for the holding company system following the acquisition. Regulators have increasingly focused on the acquirer's capacity to provide additional capital support to the insurer in stress scenarios, and a credible capital commitment plan is often the difference between a smooth approval and a prolonged deficiency exchange.

The filing must be submitted to the domestic state regulator before the acquisition closes, and a copy must be provided to the insurer, which then must provide copies to its directors. The regulator has up to 60 days from the date a complete Form A is filed to approve or disapprove the acquisition, with the right to extend. An incomplete filing does not start the clock. The domestic state regulator may request a public hearing within the review period, which extends the timeline. Counsel should plan for a total review period of 90 to 120 days from filing for a routine transaction and longer for complex or contested transactions, and set the purchase agreement drop-dead date accordingly.

The domestic state of each insurer within the acquisition perimeter is its state of domicile, which is the state where the insurer was chartered and maintains its principal regulatory relationship. The domestic state's commissioner serves as the lead regulator for Form A purposes, and the Form A filing obligation runs to that commissioner, not to the commissioners of other states where the insurer holds licenses. For an acquisition involving a single domestic insurer domiciled in one state, the lead regulator analysis is straightforward. For acquisitions involving insurance holding company groups with multiple insurers domiciled in different states, separate Form A filings may be required with each domestic state regulator.

The lead state concept has additional significance under the NAIC's group-level supervision framework, where the lead state for a group may be determined by a separate process that considers the location of the group's principal operations, the gross written premium in each state, and prior agreements among participating commissioners. The lead state for group supervision purposes may differ from the domestic states of the individual insurers within the group, and the lead state regulator may coordinate Form A review with other participating state regulators through an informal or formal collaboration process. Transactions involving large multi-state insurance groups may involve coordination among several regulators, each of whom has review rights and some of whom may have approval authority.

Identifying the lead regulator early and initiating a pre-filing conference before the Form A is submitted is a best practice that experienced insurance M&A counsel follows consistently. A pre-filing conference allows counsel to present the transaction structure, the acquirer's background, and the proposed capital plan to the regulator in an informal setting before any formal review clock starts. The regulator may identify potential concerns with the filing that can be addressed in the initial submission, reducing deficiency risk. The regulator may also confirm its view of the filing requirements, particularly for novel transaction structures such as private equity acquisitions, foreign acquirer transactions, or deals involving complex holding company arrangements that do not fit neatly within the standard Form A framework.

The biographical affidavit is among the most labor-intensive components of Form A preparation. Each person who is, or following the transaction will be, a director, officer, or other person who in fact exercises control of the acquiring entity or the insurer must complete a biographical affidavit disclosing their personal history, employment background, criminal history, regulatory history, and financial condition. The NAIC Biographical Affidavit form is detailed, and state supplements sometimes add additional disclosure requirements. Collecting completed, accurate affidavits from all required individuals, which may include fund managers, operating partners, designated board representatives, and key executives across multiple portfolio companies, is a workstream that routinely takes four to six weeks and cannot be compressed significantly.

In addition to biographical affidavits, most states require fingerprinting of certain acquiring persons for submission to the FBI and state criminal history repositories. The fingerprinting requirement creates a practical coordination challenge for transactions involving many individuals spread across multiple jurisdictions, because fingerprinting must be done through an authorized livescan provider or by submission of physical fingerprint cards, and the results must be returned and reviewed before the Form A can be deemed complete. Counsel should initiate biographical affidavit collection and fingerprinting immediately after the letter of intent is executed, because these workstreams have fixed minimum completion times that cannot be shortened regardless of how urgently the deal needs to close.

The state regulator uses biographical information to assess the competence, experience, and integrity of the proposed management of the acquiring entity and the insurer. Regulatory history of concern includes prior regulatory actions in any licensed industry, insolvency proceedings, securities violations, and criminal convictions. Prior regulatory history does not automatically disqualify an acquirer, but it must be disclosed accurately and completely. Omissions or inconsistencies in biographical affidavits are among the most serious compliance failures in the Form A process and can result in disapproval or substantial delay. Counsel must review each completed affidavit carefully and follow up on any identified issues before filing.

Form A requires the filer to submit financial projections demonstrating that the proposed acquisition will not result in the insurer being in a hazardous financial condition following the closing. The projections must show the insurer's projected statutory surplus, risk-based capital (RBC) ratios, and liquidity position over a defined post-closing period, typically three to five years, and must reflect the impact of the acquisition structure on the insurer's capital. If the acquirer intends to use intercompany dividends or service fee arrangements to move cash from the insurer to the holding company to service acquisition debt, the projections must show the insurer's capital position after those extractions and demonstrate continued compliance with statutory minimum capital requirements.

Statutory solvency analysis for insurance companies is distinct from GAAP-based financial analysis. Statutory accounting imposes different reserve standards, asset valuation rules, and surplus requirements than GAAP, and the RBC framework establishes regulatory action thresholds at defined ratios of statutory capital to risk-based capital requirements. Acquirers who approach Form A financial projections using GAAP financial models without converting to statutory accounting will produce projections that do not satisfy regulatory standards and will generate deficiency notices. Experienced insurance actuarial advisors and statutory accountants must be engaged to prepare Form A financial exhibits, and those advisors need access to the insurer's statutory financial statements, reserve studies, and RBC calculations.

Regulators also focus on book value versus market value considerations in assessing acquisition terms. The premium or discount to statutory book value at which the insurer is being acquired may raise regulatory concern if it suggests the acquirer's valuation assumptions about the insurer's reserve adequacy differ materially from the insurer's reported position. A significant premium may not be problematic, but a significant discount may prompt the regulator to request additional analysis of the acquirer's reserve assessment and the basis for the purchase price. This is particularly acute for life insurance acquisitions where embedded value and asset-liability matching are the primary value drivers, and where the purchase price may reflect a different view of the in-force block's profitability than the current reserve position implies.

The state commissioner may hold a public hearing on a Form A application on the commissioner's own motion or upon request by interested parties. Most state holding company acts specify the grounds on which a hearing may be requested and designate a period during which requests must be submitted following public notice of the filing. Interested persons who may request a hearing include policyholders, employees, labor organizations, and competing insurers, and in high-profile transactions involving large domestic carriers, hearing requests from consumer advocacy groups are common. Counsel should anticipate the possibility of a hearing for any transaction involving a large or prominent insurer, an acquirer with a controversial background, or a deal that has attracted public attention.

The statutory grounds for disapproval of a Form A application reflect the policyholder protection purpose of the holding company act. Most states authorize disapproval if the acquisition would result in the insurer's financial condition being hazardous to policyholders or creditors, if the business plan or experience of the acquiring persons renders the acquisition contrary to law or against the public interest, if the financial condition of any acquiring person might jeopardize the insurer's financial stability or prejudice policyholders, if plans to liquidate or sell the insurer within a specified period after closing are contrary to the interests of policyholders or the public, or if the acquisition would substantially lessen competition in the insurance market. These grounds are broad, and counsel must develop a responsive record addressing each potential disapproval basis during the Form A preparation process.

Conditional approvals are common in complex transactions. The commissioner may approve a Form A subject to conditions including capital maintenance commitments, restrictions on intercompany dividends for a defined period, management continuity requirements, policyholder notification obligations, or commitments to maintain the insurer's domicile and principal operations. Negotiating the scope of conditions before the formal approval order is issued is important, because conditions become part of the order and may be difficult to modify post-closing. Counsel should engage with the regulator during the review period to understand the direction of any proposed conditions and address regulatory concerns before they are memorialized in formal approval language.

Form E is a pre-acquisition notification required in states that have adopted the NAIC Pre-Acquisition Notification Model Regulation, designed to assess the competitive impact of insurance acquisitions in specific lines of business and geographic markets. Unlike the Form A, which focuses primarily on the financial condition and competence of the acquirer, Form E focuses on market concentration and the potential for the combined entity to substantially reduce competition in insurance markets. The filing requires the parties to report market share data by line of business and state for the acquirer and the target, allowing the commissioner to identify markets where the combined entity would reach or exceed concentration thresholds defined in the model regulation.

Not all states require Form E, and the filing thresholds and review standards vary among adopting states. The model regulation applies when either the acquirer or the target writes more than $10 million in direct written premium in the domestic state in the applicable lines, or when the combined entity would hold above a specified market share percentage in certain lines. States with competitive markets and multiple carriers in each major line often have less active Form E review processes, while states with concentrated markets for specific specialty lines may scrutinize acquisitions that would further concentrate those markets. Counsel should identify Form E requirements in each state with material premium exposure for either party and determine whether formal filing or a market share analysis confirming non-applicability is required.

The Form E review standard generally follows an analytic framework similar to antitrust merger review: the commissioner evaluates whether the acquisition would substantially lessen competition, considering the Herfindahl-Hirschman Index (HHI) or similar concentration metrics in each relevant market. If a market concentration concern is identified, the commissioner may condition Form A approval on divestitures, line-of-business restrictions, or market-conduct commitments, or may refer the matter to the state attorney general for antitrust review. In practice, Form E disapproval based on competitive concerns is uncommon in diversified insurance acquisitions but has occurred in transactions that would result in one carrier dominating a specialty line in a small state market. Thorough pre-filing analysis of market share data reduces the risk of surprise regulatory conditions late in the approval process.

The NAIC provides a coordinating framework for multi-state insurance regulation through its electronic filing and data-sharing systems, model law development process, and working groups that facilitate communication among state regulators on complex transactions. For Form A filings, the NAIC's System for Electronic Rate and Form Filing (SERFF) and related platforms support electronic submission to participating states, and the NAIC's filing database allows regulators to access Form A submissions filed in other states. This coordination is informal rather than binding: each domestic state retains independent authority to approve or disapprove a Form A, and no NAIC determination can substitute for state-level approval.

In practice, multi-state coordination on Form A review occurs through the NAIC's Financial Analysis Working Group and through direct communication among the domestic state regulators of the insurers in a group. The lead state for group supervision may convene a multi-state working group to coordinate review, share information, and develop a coordinated position on approval conditions. This process is most active for transactions involving large insurance groups that are systemically significant or that raise novel regulatory questions. Counsel for the acquirer should maintain communication with the lead state regulator and request information about any multi-state coordination process that is underway, because conditions developed through a multi-state working group may be broader than those a single domestic state would impose independently.

Non-domiciliary states where the insurer holds licenses generally do not conduct their own Form A review, but some states require notification or concurrent filings when a licensed insurer experiences a change of control. The assuming state notification requirement varies in form and timing: some states require filing a copy of the Form A filed with the domestic state, others require a separate notification letter, and some states have no non-domiciliary notification requirement at all. Failing to file required notifications in assuming states may not affect the insurer's license directly, but it creates a compliance gap that may be identified in subsequent market conduct examinations. Counsel should survey all states where each insurer in the transaction perimeter holds licenses and confirm the applicable notification requirements before closing.

The Form A framework applies to all domestic insurers regardless of the lines of business they write, but the substantive regulatory analysis of financial condition, reserve adequacy, and post-acquisition solvency differs significantly among life, property and casualty, and health carriers. Life insurance companies maintain long-duration liabilities that require actuarial modeling of mortality, interest rate, and lapse assumptions, and the regulatory review of a life company acquisition focuses heavily on the in-force block's embedded value, asset-liability matching, and reserve adequacy under stress interest rate scenarios. The acquirer's actuarial credentialing and access to the insurer's reserve studies are threshold concerns in any life company acquisition.

Property and casualty carriers maintain shorter-duration liabilities but face reserve uncertainty from latent claim development, catastrophe exposure, and claims-in-litigation. Form A review for P&C acquisitions focuses on the adequacy of loss reserves, the insurer's reinsurance program and counterparty credit risk, and the catastrophe exposure management plan under the new ownership. Regulators in hurricane, earthquake, or severe weather exposed states may impose post-closing requirements on P&C carriers regarding catastrophe reinsurance purchasing levels and capital maintenance following catastrophe events. Health carrier acquisitions layer additional regulatory complexity from state and federal health insurance law, including ACA market conduct requirements, network adequacy standards, and state-specific reserve requirements for health maintenance organizations.

Multi-line carriers that write both life and P&C business, or carriers that write health alongside P&C lines, require an integrated regulatory analysis that addresses each line's specific risk profile and the interaction effects between lines on the insurer's aggregate solvency position. Reinsurance arrangements, quota share treaties, and intercompany pooling agreements that cross line boundaries must be disclosed in the Form A and analyzed for their effect on the insurer's net retained risk. Regulators reviewing a multi-line acquisition may engage multiple specialty examiners, and the review process may be more complex and time-consuming than for a single-line carrier. Counsel should confirm the domestic state regulator's staffing and experience with multi-line carriers and adjust the regulatory timeline estimate accordingly.

Surplus lines insurers operate under a fundamentally different licensing framework from admitted carriers. A surplus lines insurer is licensed in its home state and approved as an eligible surplus lines insurer in states where it writes business through surplus lines brokers, but it does not hold an individual license in each state where it places coverage. The acquisition of a surplus lines insurer triggers Form A review in the insurer's home state, which is typically the state where the company is domiciled and licensed as a non-admitted insurer. The post-acquisition holding company structure must remain acceptable under the home state's surplus lines licensing rules, and the acquirer must confirm that the proposed ownership does not impair the insurer's eligibility in its home state.

Beyond the home state Form A, the acquisition of a surplus lines carrier may affect the insurer's eligibility to write surplus lines in other states. Many states impose financial strength requirements, ownership criteria, or holding company disclosure obligations on surplus lines insurers seeking or maintaining eligibility. A change in control may require the insurer to re-file for eligibility in states that require approval of ownership changes, or to provide notification to states that require disclosure without formal approval. The scope of re-qualification requirements depends on each state's surplus lines eligibility rules, which are codified in statute, regulation, or administrative bulletins that vary considerably from state to state. Counsel should conduct a state-by-state eligibility audit as part of transaction planning.

Reinsurance acquisitions involve a distinct regulatory analysis. Reinsurers that are licensed in a domestic state are subject to the Form A requirements of that state. Reinsurers that operate as unauthorized reinsurers or that rely on credit for reinsurance through trust fund or letter of credit arrangements may face specific regulatory scrutiny of how those arrangements will be maintained or modified following the acquisition. The acquisition of a significant reinsurance counterparty of a domestic insurer may also trigger disclosure obligations under the domestic insurer's reinsurance agreements, and the parties must confirm that the acquisition does not constitute an event of default under key reinsurance treaties. Reinsurance contract review is a distinct due diligence workstream that must be completed before closing.

A mutual insurance company is owned by its policyholders rather than by shareholders, and has no voting equity securities. As a result, the 10% control presumption under the holding company act does not apply to a mutual insurer in the same way it applies to a stock insurer. However, the acquisition of control of a mutual insurer or a mutual holding company that controls a stock insurer subsidiary is still subject to regulatory approval under state law, and the form of that approval depends on how the transaction is structured. A demutualization converts a mutual insurer to a stock insurer by issuing shares to policyholders and simultaneously conducting an IPO or private placement, transforming the company from policyholder-owned to shareholder-owned in a single transaction that requires extensive regulatory and court approval.

Demutualization transactions are among the most complex in insurance M&A. The conversion plan must be approved by the state insurance commissioner following a review of the proposed distribution of consideration to policyholders, the actuarial fairness of the conversion terms, and the financial condition of the converted company. Policyholders typically receive a combination of shares in the resulting stock company, cash, or enhanced policy benefits in exchange for their membership interests, and the allocation formula must satisfy regulatory standards for equitable treatment. Courts in most states must also approve the conversion plan following notice to policyholders and an opportunity for objection. The combined regulatory and court approval process for a demutualization typically takes 12 to 24 months, making demutualization one of the longest-timeline transactions in insurance M&A.

Mutual holding company (MHC) conversions present a related but distinct set of issues. An MHC structure allows a mutual insurer to convert to a stock company while retaining a majority stake in the resulting stock insurer through a mutual holding company that is itself owned by policyholders. The MHC may later sell minority interests in the stock insurer through an IPO or secondary offerings, and may eventually pursue a full demutualization by distributing its shares in the stock insurer to policyholders. Any change in control at the MHC level or involving the stock insurer subsidiary requires regulatory approval, and the holding company structure created by the MHC conversion must be registered and maintained under the holding company act in the insurer's domestic state on an ongoing basis.

Foreign acquisitions of U.S. insurance companies are subject to review by the Committee on Foreign Investment in the United States (CFIUS) when the transaction involves a foreign person acquiring control or a non-controlling interest with certain governance rights in a U.S. business that qualifies as a covered business under the CFIUS regulations. Insurance companies that maintain sensitive policyholder personally identifiable information (PII) at scale may qualify as TID US businesses subject to mandatory CFIUS declaration requirements, depending on the volume and sensitivity of the data and the acquirer's country of origin. For insurance acquisitions by foreign private equity funds with sovereign wealth fund limited partners or by foreign strategic carriers, the CFIUS analysis must be conducted at the outset of transaction planning to assess mandatory declaration obligations and potential jurisdiction risk.

CFIUS and state insurance regulatory reviews run on parallel tracks with different substantive standards. CFIUS focuses on national security risk, including data security, critical infrastructure, and foreign government influence. State insurance regulators focus on policyholder protection, financial solvency, and the competence of proposed management. The information required for each filing overlaps but does not duplicate: CFIUS requires detailed foreign ownership and government nexus disclosure that may not be in standard Form A format, while Form A requires actuarial and solvency analysis that is not part of CFIUS review. Coordinating the two filings requires experienced counsel in both CFIUS and insurance regulatory practice, and the two workstreams must be managed simultaneously with attention to overlapping confidentiality requirements and government-to-government information sharing risks.

CFIUS mitigation agreements for foreign insurance acquirers have included data security plans governing the handling of U.S. policyholder PII, board composition restrictions limiting foreign national participation, requirements for U.S.-person security officers with access to sensitive data, and restrictions on the insurer's ability to transfer policyholder data outside the United States. These mitigation measures must be drafted in coordination with state insurance regulatory conditions to avoid conflicts between the CFIUS order and the Form A approval conditions. For transactions in which both CFIUS and multiple state Form A approvals are required, the overall regulatory approval workstream is among the most complex in cross-border M&A, and the transaction structure should be designed from the outset to minimize the friction between the two regulatory frameworks.

The insurance holding company act imposes prior approval requirements on extraordinary dividends and certain intercompany transactions that could transfer capital from a domestic insurer to affiliates in the holding company structure. An extraordinary dividend is generally defined as any dividend or distribution that, together with all dividends paid in the preceding 12 months, exceeds the greater of 10% of the insurer's statutory surplus as of the prior December 31 or the insurer's net income from operations for the prior year, excluding realized capital gains. Dividends within this threshold are ordinary dividends requiring advance notice but not prior approval. Dividends above the threshold are extraordinary and require prior approval from the domestic state commissioner before payment.

For acquisition financing structures that rely on dividend flows from the insurer to service holding company debt, the extraordinary dividend threshold is a critical planning parameter. A highly leveraged acquisition that requires large initial dividend payments from the insurer to the acquirer's intermediate holding companies may hit the extraordinary dividend threshold in the first year of ownership, requiring prior regulatory approval before the debt service schedule can be met. Regulators who approved a Form A with specific conditions about capital maintenance may be reluctant to approve extraordinary dividends that would undermine those conditions immediately after closing. Counsel should model the ordinary dividend capacity of the insurer against the proposed debt service schedule before the acquisition financing is committed to identify any structural mismatch.

Intercompany transactions beyond ordinary dividends also face oversight. Management services agreements, cost-sharing arrangements, tax-sharing agreements, reinsurance arrangements, and loans between the insurer and its affiliates are subject to affiliated transaction provisions of the holding company act, which require either prior approval or prior notice depending on the transaction type and dollar threshold. Most states require prior approval for transactions exceeding the greater of 3% or 5% of the insurer's admitted assets, and some states apply lower thresholds for specific transaction types. Post-closing integration plans that involve transitional service agreements, shared employee arrangements, or intercompany reinsurance should be reviewed against the affiliated transaction provisions of each domestic state before implementation.

Following a Form A-approved acquisition, the insurer and each person that is a member of the insurance holding company system must maintain the holding company registration required under the state holding company act. The Form B annual registration statement requires disclosure of the insurer's current holding company structure, identification of all entities within the group, disclosure of intercompany transactions, and identification of all persons holding 10% or more of any class of voting security of any entity in the chain from the insurer to the ultimate controlling person. The Form B must be filed annually by each registered insurer in the domestic state, and material changes to the holding company structure must be reported promptly.

Post-closing holding company structure changes are common in private equity-owned insurance groups as the acquirer undertakes portfolio rationalization, upstream mergers of intermediate holding companies, or downstream reorganizations of the insurer's operating subsidiaries. Each of these changes must be evaluated for whether it constitutes a new change of control requiring a fresh Form A filing or a material amendment requiring prior notification or approval under the holding company act. An upstream merger that results in a different entity becoming the direct parent of the registered holding company may trigger Form A requirements even though the ultimate beneficial owner has not changed. Counsel should develop a regulatory change management protocol at closing that routes all proposed post-closing structural changes through a compliance review before implementation.

Part 4 and Part 5 filings under certain state holding company acts address specific types of holding company transactions that require separate approval. Part 4 filings cover certain intercompany agreements and transactions, and Part 5 filings address the acquisition of assets or the formation of subsidiaries by a registered insurer. The terminology and specific requirements vary by state, with some states using NAIC model language and others using their own numbering conventions. The practical point is that a broad range of post-closing business activities that appear routine from a corporate law perspective, including forming a new subsidiary, entering a new reinsurance arrangement, or acquiring a block of policies from another carrier, may require regulatory filing or approval in the insurer's domestic state under the holding company act framework that applies to activities within the registered holding company system.

The Own Risk and Solvency Assessment (ORSA) is an internal risk management process and annual regulatory filing required for insurance groups and individual insurers that meet defined premium thresholds, as adopted in most states pursuant to the NAIC ORSA Model Act. The ORSA requires the insurer or group to conduct an internal assessment of its current and future solvency position, including a forward-looking analysis of risks that could affect its capital adequacy under a range of stress scenarios. The results of this assessment are documented in an ORSA Summary Report that is filed annually with the lead state regulator on a confidential basis. The ORSA process must be proportionate to the size and complexity of the insurer's operations and must be integrated into the insurer's governance and risk management framework.

In an M&A context, the ORSA Summary Report is a valuable due diligence document that reveals the insurer's internal view of its risk profile, capital adequacy, and stress resilience in a way that statutory financial statements alone do not capture. A well-developed ORSA demonstrates that the insurer's risk management function is mature and that management has a clear understanding of the risks inherent in the business. A poorly developed ORSA may signal risk management deficiencies that represent post-closing operational risk for the acquirer. Regulators who observe a change in control are likely to scrutinize the next ORSA filing closely to assess whether the new ownership has maintained or enhanced the insurer's risk management capabilities.

Following the acquisition, the acquiring group must integrate the acquired insurer into its group-level ORSA process if the group itself meets ORSA thresholds. This integration may require significant work if the acquired insurer uses different risk modeling systems, stress scenario frameworks, or risk appetite metrics than the acquiring group. The post-closing ORSA integration plan should be developed during the due diligence phase, with input from the risk management functions of both organizations, so that the acquirer understands the scope of the integration work required and can plan the resources and timeline needed to produce a compliant consolidated ORSA within the first annual cycle following closing.

The representations and warranties in an insurance company purchase agreement must address the full scope of the regulatory framework governing the insurer's operations. Standard M&A reps covering organization, capitalization, financial statements, and material contracts must be supplemented with insurance-specific reps covering the insurer's domestic state licenses and certificates of authority, compliance with holding company act filing requirements, the status of any pending or threatened regulatory actions, the accuracy and completeness of statutory financial filings, the adequacy of loss reserves as of a specified date, the terms and status of material reinsurance agreements, and the insurer's compliance with market conduct standards in each state where it writes business. Reserve adequacy reps are among the most negotiated in insurance M&A because reserve development is inherently uncertain and sellers resist representations that could expose them to indemnification claims based on post-closing adverse development.

The regulatory approval covenants in the purchase agreement govern each party's obligations with respect to the Form A filing process and other required regulatory approvals. Standard regulatory approval covenants require both parties to cooperate in preparing and filing applications, to provide information requested by regulators on a timely basis, to use commercially reasonable or best efforts to obtain approvals, and to refrain from taking actions that would reasonably be expected to impair or delay regulatory approval. For insurance transactions, the regulatory approval covenant should specify which party is responsible for Form A preparation, how information requests and deficiency responses are handled, how pre-filing conferences with regulators are managed, and what commitments or conditions each party is authorized to make to regulators on the other party's behalf.

The termination right associated with the regulatory approval condition is among the most consequential provisions in the purchase agreement. Most purchase agreements provide that either party may terminate if regulatory approval has not been obtained by a specified drop-dead date. In insurance transactions, the drop-dead date must be set with a realistic assessment of Form A review timelines in the applicable domestic states, accounting for the possibility of deficiency notices, public hearings, and multi-state coordination processes. A drop-dead date set too early creates tactical leverage for a party seeking to exit the transaction. A drop-dead date set too late may lock the parties into an extended engagement that is no longer commercially viable. Experienced insurance M&A counsel calibrate the drop-dead date based on prior experience with the specific domestic state regulators involved and the complexity of the transaction.

Representations and warranties (R&W) insurance has become a standard tool in private M&A transactions for transferring indemnification risk from the seller to an insurance carrier, allowing clean exits by sellers while providing buyers with an independent source of recovery for rep and warranty breaches. In insurance company M&A, R&W insurance interacts with the target's operations in a distinctive way: the underwriter of the R&W policy is essentially insuring the accuracy of representations about an insured entity whose primary business is writing insurance. This creates a specific underwriting dynamic in which the R&W insurer must assess risks that are unusual for standard M&A representations, including reserve adequacy, regulatory compliance, and the financial condition of reinsurance counterparties.

R&W underwriters in insurance company M&A transactions typically impose exclusions for certain categories of risk that they view as too difficult to underwrite or as better addressed through specialist insurance products. Common exclusions include losses arising from adverse loss reserve development beyond the amount reserved as of the closing date, losses from regulatory actions initiated after closing based on pre-closing conduct, losses related to specific identified claims in litigation, and losses from changes in statutory reserve requirements or actuarial methodology following closing. The scope of these exclusions is heavily negotiated and varies among underwriters. Buyers should understand that a R&W policy in an insurance company transaction may provide less complete coverage than a comparable policy in a non-insurance transaction, and should assess whether gap coverage through a separate adverse development cover or reserve strengthening mechanism is warranted.

The reserve adequacy representation is the most difficult insurance-specific rep to underwrite. R&W insurers generally require an actuarial analysis of the insurer's reserves prepared by an independent actuary as a condition to underwriting reserve adequacy coverage. The scope of the actuarial review, the standards applied, and the range of actuarial uncertainty acknowledged in the report affect what the R&W insurer will cover and at what retention level. Buyers should engage their actuarial advisors early to understand the feasibility and scope of actuarial due diligence that will support the R&W underwriting process, and should factor the timing of the actuarial review into the overall due diligence timeline to avoid delays in R&W policy binding that could delay closing.

The day a Form A-approved insurance acquisition closes is the beginning of a permanent regulatory relationship, not the end of the regulatory process. The holding company group immediately acquires a suite of ongoing reporting obligations that must be maintained without interruption. The Form B annual holding company registration statement must be filed in each domestic state by each registered insurer within the group, typically within a fixed period after the end of the insurer's fiscal year. The Form B discloses the current holding company structure, identifies all entities in the group, reports intercompany transactions during the year, and identifies all persons holding 10% or more of any voting security in the holding company chain. Material changes to the information in a prior Form B must be reported promptly as they occur.

The Form F enterprise risk report is required in states that have adopted the NAIC's Enterprise Risk Report Model, which requires the ultimate controlling person of a registered holding company system to file an annual report identifying the material risks within the group that could have a significant impact on the financial condition of the domestic insurer. The Form F must address group-wide capital, liquidity, internal risk management controls, and the enterprise risk management framework. Filing responsibilities for Form F are distinct from Form B: the Form F obligation runs to the ultimate controlling person of the group, which may be an entity located outside the domestic state or even outside the United States. Establishing the Form F filing entity and its reporting framework at closing is a post-closing compliance priority.

The ongoing dividend management process requires a compliance calendar that tracks ordinary dividend notice periods and extraordinary dividend approval timelines against the holding company's cash needs and debt service obligations. An insurer that misses a notice or approval requirement by paying a dividend without completing the required regulatory process creates a compliance violation that may result in enforcement action, required return of the dividend, or adverse regulatory consequences in subsequent Form A or other regulatory proceedings. Counsel should work with the insurer's finance function to establish a dividend management protocol that integrates the regulatory requirements into the annual treasury planning process, and that provides adequate lead time for extraordinary dividend applications in years when dividend needs are projected to exceed the ordinary threshold.